MDS Pharma Services Wins Two Good Clinical Practice Journal Awards

Contract research organization honored for excellence in clinical-trial
management

KING OF PRUSSIA, PA., Oct. 23 /PRNewswire-FirstCall/ - MDS Pharma Services, a
leading provider of innovative drug-discovery and development solutions, last
night won two awards for superior clinical-trial management at the Good
Clinical Practice Journal (GCPj) Awards event in London.
The contract research organization won top honors for Data Management Team of
the Year and Project Manager of the Year. Additionally, MDS Pharma Services
was a finalist in the Clinical Research Team of the Year and Most Innovative
Patient Recruitment Strategy categories.
"Winning two 2008 GCPj Awards and being a finalist for two more is a testament
to the people, processes and services we deploy on behalf of our biotech and
pharmaceutical clients," said MDS Pharma Services President David Spaight.
"These achievements exemplify our commitment to client service and
high-quality, on-time planning and execution of clinical research."
More than 350 pharmaceutical and biotech industry executives from around the
world attended the GCPj Awards program. Now in its second year, the GCPj
Awards competition celebrates innovation and excellence in clinical research.
The MDS Pharma Services team in France was recognized as Data Management Team
of the Year for concluding a client project two weeks ahead of schedule,
despite being involved in a number of other clinical research projects with
aggressive timelines. The team's exemplary performance has resulted in a high
degree of client satisfaction, which has generated repeat business.
Dr. Elvira Krauss of MDS Pharma Services in Germany was honored as Project
Manager of the Year for her exceptional handling of a number of regional and
global clinical-research projects across a range of therapeutic areas,
including vaccines, neurology, immunology, gastroenterology, cardiovascular
and respiratory.

About MDS Pharma Services

MDS Pharma Services is committed to delivering quality service on time. We
offer a full spectrum of resources to meet the drug discovery and development
needs of the pharmaceutical and biotechnology industries. With numerous
facilities strategically located around the world, we apply advanced
scientific and technological expertise throughout the drug discovery and
development process - from lead optimization, pre-IND research, early clinical
research (bioequivalence, phases I-IIa) and bioanalysis through to global
clinical development (phases IIb-IV), central lab and centralized cardiac
services. For more information, visit our website at www.mdsps.com.
MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a
global life sciences company that provides market-leading products and
services that our customers need for the development of drugs and diagnosis
and treatment of disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging, radiotherapeutics,
and analytical instruments. MDS has more than 5,500 highly skilled people in
29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24
hours a day.

SOURCE MDS Inc.

For Media, Charlene McGrady, (610) 239-7900, ext. 231,
charlene.mcgrady@mdsinc.com; For Investors, Kim Lee, (416) 675-6777, ext.
32606, kim.lee@mdsinc.com